Zoetis Inc. (ZTS) Financials

ZTS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 15.2 billion 11.9 billion
Dec. 31, 2025 15.5 billion 12.1 billion
Sept. 30, 2025 15.2 billion 9.8 billion
June 30, 2025 14.5 billion 9.5 billion

ZTS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 291.0 million 25.0 million
Dec. 31, 2025 732.0 million 22.0 million
Sept. 30, 2025 805.0 million 22.0 million
June 30, 2025 308.0 million 22.0 million

ZTS Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 601.0 million
Dec. 31, 2025 603.0 million
Sept. 30, 2025 721.0 million
June 30, 2025 718.0 million

ZTS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.9 billion 193.0 million 193.0 million
Dec. 31, 2025 2.3 billion 9.2 billion 202.0 million
Sept. 30, 2025 2.1 billion 7.1 billion 204.0 million
June 30, 2025 1.4 billion 5.2 billion 210.0 million

ZTS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 422.4 million
Dec. 31, 2025 438.6 million
Sept. 30, 2025 443.2 million
June 30, 2025 445.5 million

ZTS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 110.0 million 180.0 million 588.0 million -
Dec. 31, 2025 161.0 million 199.0 million 619.0 million -
Sept. 30, 2025 133.0 million 170.0 million 579.0 million -
June 30, 2025 178.0 million 172.0 million 617.0 million -

ZTS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.3 billion 641.0 million
Dec. 31, 2025 2.4 billion 743.0 million
Sept. 30, 2025 2.4 billion 715.0 million
June 30, 2025 2.5 billion 682.0 million

ZTS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ZTS

List: Contenders

Price: $79.52

52 week price:
72.38
171.52

Dividend Yield: 2.65%

5-year range yield:
0.48%
2.65%

Forward Dividend Yield: 2.67%

Payout Ratio: 33.88%

Payout Ratio Range:
-116.22%
4077.78%

Dividend Per Share: 2.12 USD

Earnings Per Share: 6.10 USD

P/E Ratio: 12.19

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 1.6 million

Ebitda: 543.0 million

Market Capitalization: 32.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 14

DGR3: 17.50%

DGR5: 20.78%

DGR10: 19.77%

Links: